Melhorando a disponibilidade de fósforo da rocha fosfórica de patos para Eucalipto: um estudo com radiotraçador 32P

Eucalyptus plantation in Brazil is generally set on low fertility soils, therefore phosphorus (P) fertilization is mandatory and increases the cost of plantation operation. Using species that more efficiently uptake phosphorus from less soluble sources is an interesting option. However, little is known about eucalyptus regarding its ability of using less soluble forms of phosphorus. The use of P by eucalyptus (E. urophylla, E. grandis, and E. urophylla ;´; E. grandis) was studied in greenhouse using a loamy-textured, hipodystrophic Typic Haplustox from the Cerrado region, and 32P isotopic method. The P sources tested were triple superphosphate (TSP), phosphate rock (PR) and the triple superphosphate mixed with PR (TSP+PR). The effectiveness of P sources in terms of increasing dry matter yield was TSP = (TSP + PR) >; PR, and the P uptake followed the order (TSP + PR) >; TSP >; PR for both species plus the hybrid. The increase in P uptake from PR due to TSP influence was 217.3% for E. urophylla, 235.7% for E. grandis, and 28.7% for E. urophylla ;´; E. grandis, indicating an enhancement effect of TSP on the effectiveness of PR. The hybrid E. urophylla ;´; E. grandis was the most efficient genotype on P soil use and E. grandis most exigent in P fertilizer.Como geralmente os solos usados para plantações de eucalipto no Brasil são de baixa fertilidade, a adubação fosfórica é indispensável, incrementando o custo da plantação. Espécies mais eficientes no uso de fósforo (P) de fontes pouco solúveis poderiam ser uma opção interessante. Porém, pouco se conhece ainda sobre o comportamento de eucalipto em relação à capacidade de usar fósforo de fontes com diferente solubilidade em água. O uso de P por eucalipto (E. urophylla, E. grandis, and E. urophylla ;´; E. grandis), foi estudado em experimento de casa de vegetação usando solo da Região de Cerrado, Latossolo Vermelho Amarelo hypodistrófico, e o método isotópico com 32P. As fontes de P usadas foram superfosfato triplo (SFT), rocha fosfórica (RF) e a mistura de superfosfato triplo com rocha fosfórica (SFT+RF). A eficácia das fontes de P em termos do aumento do rendimento de matéria seca seguiu a ordem SFT = (SFT + RF) >; RF e de P absorvido a ordem (SFT + RF) >; SFT >; RF por ambas as espécies e o híbrido de eucalipto. O incremento na absorção de P de RF, influenciada pela mistura com SFT foi de 217,3% em E. urophylla, 235,7% em E. grandis e 28,7% em E. urophylla ;´; E. grandis, indicando o efeito benéfico do SFT sobre a efetividade da RF. O híbrido E. urophylla ;´; E. grandis foi o genótipo mais eficiente no uso de P do solo e E. grandis o mais exigente em P do fertilizante

Phosphorus utilization by corn as affected by green manure, nitrogen and phosphorus fertilizers

O objetivo deste trabalho foi avaliar a utilização, pela planta de milho, do P proveniente de superfosfato triplo marcado com 32P (32P‑SFT), e do P proveniente do solo influenciado por doses de N e pelos adubos verdes (AV) crotalária (Crotalaria juncea) e milheto (Pennisetum glaucum). O experimento foi realizado em vasos com 5 kg de Latossolo Vermelho distroférrico. Utilizou-se o delineamento inteiramente casualizado, em arranjo fatorial 4x4x2, com quatro repetições. Os tratamentos foram: quatro doses de P, na forma de SFT (0, 0,175, 0,350 e 0,700 g de P por vaso); quatro doses de N, na forma de ureia (0, 0,75, 1,50 e 2,25 g de N por vaso); e crotalária ou milheto, como adubo verde. Foram levadas em consideração as adições de P e N pelos AV. Após a maturação fisiológica dos grãos, foram avaliados: a produção de matéria seca de milho, o teor de P, o P acumulado e o aproveitamento de P nos diferentes tratamentos. O aproveitamento do 32P‑SFT pelo milho aumentou com o incremento da dose de N e diminuiu com o aumento da dose de 32P‑SFT. O fertilizante mineral fornece a maior parte do P acumulado nas plantas de milho. O aproveitamento do 32P‑SFT pelo milho foi de 13,12%, em média. A espécie de adubo verde influencia a assimilação de 32P‑SFT pelas plantas.  The objective of this work was to evaluate the utilization by corn plants of P from triple superphosphate fertilizer labeled with 32P (32P‑TSP), and of P from soil as affected by N rates and by the green manures (GM) sunn hemp (Crotalaria juncea) and millet (Pennisetum glaucum). The experiment was carried out using pots filled with 5 kg Oxisol (Rhodic Hapludox). A completely randomized design was used, in a 4x4x2 factorial arrangement, with four replicates. The treatments were: four P rates as TSP (0, 0.175, 0.350, and 0.700 g P per pot); four N rates as urea (0, 0.75, 1.50, and 2.25 g N per pot); and sunn hemp or millet as green manure. The additions of N and P by the GM were taken into account. After grain physiologic maturation, corn dry matter, P contents, accumulated P, and P recovery in the different treatments were measured. 32P‑TSP recovery by corn increased with N increasing rates, and decreased with increasing rates of 32P‑TSP. The mineral fertilizer provides most of the accumulated P by corn plants. The recovery of 32P‑TSP by corn was 13.12% in average. The green manure species influence the assimilation of 32P‑TSP by the plants

Aproveitamento de nitrogênio pelo milho, em razão da adubação verde, nitrogenada e fosfatada

The objectives of this work were to evaluate corn (Zea mays) nitrogen (N) utilization from the green manure crops sunnhemp (Crotalaria juncea) and millet (Pennisetum glaucum L.) and from urea, and to calculate the contribution of soil N to the mineral nutrition of corn, as affected by nitrogen and phosphorus mineral fertilizers. The experiment was conducted in a greenhouse, in pots with 5 kg of soil (Rhodic Hapludox). The experimental design was completely randomized, with 32 treatments and four replicates, in a 4x4x2 factorial array. The treatments were combinations of four N rates as urea: 0, 0.75, 1.50 and 2.25 g N per pot (labeled or not with 15N); four P rates as triple superphosphate: 0, 0.175, 0.350 and 0.700 g P per pot; and sunnhemp and millet labeled or not with 15N. Green manure dry matter provided 1 g N per pot. Corn plants were evaluated for dry mass yield, accumulated N, and N utilization from green manures, urea, and the soil. The mineral fertilizer supplied the largest amount of N to the corn plants, followed by N from soil and from green manures. The N utilization from sunnhemp by corn plants was greater than the N utilization from millet. The phosphorus application increased the assimilation of N from urea and from green manures.O objetivo deste trabalho foi avaliar o aproveitamento, pelo milho (Zea mays L.), do nitrogênio (N) proveniente da ureia, de restos culturais da crotalária (Crotalaria juncea) e do milheto (Pennisetum glaucum), e do solo, em função da adubação nitrogenada e fosfatada. O experimento foi conduzido em casa de vegetação, em vasos com 5 kg de solo (Latossolo Vermelho distroférrico). Utilizou-se o delineamento inteiramente ao acaso, com 32 tratamentos e 4 repetições, dispostos em esquema fatorial 4x4x2. Os tratamentos consistiram da combinação de quatro doses de N, na forma de ureia – 0, 0,75, 1,50 e 2,25 g por vaso (com ou sem marcação com 15N); quatro doses de P, na forma de superfosfato triplo – 0, 0,175, 0,350 e 0,700 g por vaso; e dois tipos de adubo verde, com ou sem marcação com 15N – crotalária e milheto, com adição de matéria seca equivalente a 1 g de N por vaso. Foram avaliados a produtividade de matéria seca, a quantidade de N acumulado e o aproveitamento do N pelo milho. O fertilizante mineral forneceu a maior parte do N acumulado nas plantas de milho, seguido pelo N do solo e de adubos verdes. O aproveitamento do N proveniente da crotalária, pelo milho, foi maior que o do N do milheto. A aplicação de fósforo aumentou a assimilação do N proveniente da ureia e de adubos verdes

Cd phytoavailability in sewage sludge-amended soil of different pH estimated by an isotopic method and chemical extraction

The Cd phytoavailability in sewage sludge-amended soils of different pHs using the 109Cd L-value isotopic method and Cd extracted by DTPA has been determined. Maize plants (Zea mais L.) were grown under greenhouse conditions in a xanthic ferralsol at different pHs amended with five sewage sludge (SS) rates, and labeled with 74 kBq kg-1 of 109Cd. The SS rates altered the properties of the soil chemicals and these influenced the isotopic parameter (L-value) and percent of Cd uptake by plants from soil (%Cdpdfs) and SS (%CdpdfSS). L-values and Cd extracted by DTPA correlate significantly with SS rates and Cd uptake by plants and are efficient for predicting the Cd phytoavailability in the sewage sludge-amended soil.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP

Chemical changes and zinc phytoavailability in sewage sludge-amended soil estimated by the isotopic method

Zn availability in Red Latossol (Rhodic Ferralsol) of different pH amended with different rates of sewage sludge was studied by the isotopic 65Zn L value method. Soil chemical properties were found to be altered by SS addition. Zn concentration and Zn derived from SS (ZnpfSS) in plant, and Zn phytoavailability (L value), were increased with increasing SS rates. The linear correlation coefficient of plant Zn with SS rates and with L value was significant at 1% probability. The L value proved an efficient method for predicting Zn phytoavailability in sewage sludge-amended soil with different pH under the soil conditions studied

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. METHODS: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. FINDINGS: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. INTERPRETATION: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic. FUNDING: Bill & Melinda Gates Foundation

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

The original version of this article unfortunately contained a mistake